| Annie I Iriye, MD | |
|
201 16th Ave E, Seattle, WA 98112-5226 | |
| (206) 326-3000 | |
| Not Available |
| Full Name | Annie I Iriye |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology |
| Location | 201 16th Ave E, Seattle, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639234859 | NPI | - | NPPES |
| 8237786 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | MD00036988 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Annie I Iriye, MD 201 16th Ave E, Seattle, WA 98112-5226 Ph: (206) 326-3000 | Annie I Iriye, MD 201 16th Ave E, Seattle, WA 98112-5226 Ph: (206) 326-3000 |
News Archive
A new device worn like a visor can detect emergent large-vessel occlusion in patients with suspected stroke with 92 percent accuracy, report clinical investigators at the Medical University of South Carolina, Mount Sinai, the University of Tennessee Health Sciences Center and elsewhere in an article published online on March 6, 2018, in the Journal of Neurointerventional Surgery.
BioSight, Ltd, an Israeli pharmaceutical development company focused on the development of innovative chemotherapy pro-drugs with reduced toxicity, announced today the closing of an investment of $13M led by the Mori Arkin's pharmaceutical investment firm, Arkin Holdings, and the US based venture firm Primera Capital. Proceeds of the financing will be used to fund a multi-center phase IIb clinical trial with the company's lead product, Astarabine™, for the treatment of AML.
Action this week is critical if a deal is to be reached this year, The Washington Post reports. Most analysts appear to agree that the contours of such an agreement are clear, but the specifics - which include raising taxes as well as spending reductions for Medicare and Medicaid - remain challenging and politically divisive.
Lower awareness of COVID-19, poorer health and economic conditions could reduce the effectiveness of lockdowns in developing countries, according to researchers from The University of Western Australia.
Breast cancer survivors turned advocates are working with State and Federal lawmakers to enact legislation designed to require physician to communicate important breast health information that could lead to better detection.
› Verified 9 days ago
Dr. Jaime Marie Michaelson, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 310 15th Ave E, Seattle, WA 98112 Phone: 206-326-3000 | |
Alisa Beth Kachikis, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1959 Ne Pacific St, 3rd Floor Sw 350, Seattle, WA 98195 Phone: 206-598-4070 | |
Karen L. Bohmke, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1101 Madison St, #1150, Seattle, WA 98104 Phone: 206-386-3400 | |
Lisa S. Callegari, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1959 Ne Pacific St, Seattle, WA 98195 Phone: 206-520-5000 | |
Anne-marie Elizabeth Amies Oelschlager, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: Uwmc-roosevelt, 4245 Roosevelt Way Ne, Seattle, WA 98105 Phone: 206-598-5500 | |
Shirley Andrews, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1560 N 115th St Ste 212, Seattle, WA 98133 Phone: 206-363-2800 Fax: 206-363-2811 | |
Lyndsey Summer Benson, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1959 Ne Pacific St, Box 356460, Seattle, WA 98195 Phone: 610-202-4028 |